JP2023507774A5 - - Google Patents

Info

Publication number
JP2023507774A5
JP2023507774A5 JP2022538083A JP2022538083A JP2023507774A5 JP 2023507774 A5 JP2023507774 A5 JP 2023507774A5 JP 2022538083 A JP2022538083 A JP 2022538083A JP 2022538083 A JP2022538083 A JP 2022538083A JP 2023507774 A5 JP2023507774 A5 JP 2023507774A5
Authority
JP
Japan
Prior art keywords
fluoro
thiadiazolidine
trione
hydroxy
naphthalene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022538083A
Other languages
English (en)
Japanese (ja)
Other versions
JP7751582B2 (ja
JP2023507774A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/066104 external-priority patent/WO2021127499A1/en
Publication of JP2023507774A publication Critical patent/JP2023507774A/ja
Publication of JP2023507774A5 publication Critical patent/JP2023507774A5/ja
Priority to JP2025159693A priority Critical patent/JP2026004380A/ja
Application granted granted Critical
Publication of JP7751582B2 publication Critical patent/JP7751582B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022538083A 2019-12-18 2020-12-18 タンパク質チロシンホスファターゼ阻害剤及びそれらの使用方法 Active JP7751582B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025159693A JP2026004380A (ja) 2019-12-18 2025-09-26 タンパク質チロシンホスファターゼ阻害剤及びそれらの使用方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962949613P 2019-12-18 2019-12-18
US62/949,613 2019-12-18
PCT/US2020/066104 WO2021127499A1 (en) 2019-12-18 2020-12-18 Protein tyrosine phosphatase inhibitors and methods of use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025159693A Division JP2026004380A (ja) 2019-12-18 2025-09-26 タンパク質チロシンホスファターゼ阻害剤及びそれらの使用方法

Publications (3)

Publication Number Publication Date
JP2023507774A JP2023507774A (ja) 2023-02-27
JP2023507774A5 true JP2023507774A5 (https=) 2023-12-20
JP7751582B2 JP7751582B2 (ja) 2025-10-08

Family

ID=74195125

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022538083A Active JP7751582B2 (ja) 2019-12-18 2020-12-18 タンパク質チロシンホスファターゼ阻害剤及びそれらの使用方法
JP2025159693A Pending JP2026004380A (ja) 2019-12-18 2025-09-26 タンパク質チロシンホスファターゼ阻害剤及びそれらの使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025159693A Pending JP2026004380A (ja) 2019-12-18 2025-09-26 タンパク質チロシンホスファターゼ阻害剤及びそれらの使用方法

Country Status (8)

Country Link
US (1) US20230019236A1 (https=)
EP (1) EP4077291A1 (https=)
JP (2) JP7751582B2 (https=)
CN (1) CN116348455A (https=)
AU (1) AU2020407648A1 (https=)
CA (1) CA3162069A1 (https=)
MX (1) MX2022007441A (https=)
WO (1) WO2021127499A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4073242A4 (en) 2019-12-12 2024-01-03 Kumquat Biosciences Inc. Compositions and methods for potentiating immune activity
WO2023086498A1 (en) * 2021-11-11 2023-05-19 Calico Life Sciences Llc Protein tyrosine phosphatase inhibitors and methods of use thereof
MX2024005656A (es) * 2021-11-11 2024-08-06 Calico Life Sciences Llc Inhibidores de proteina tirosina fosfatasa y metodos de uso de estos.
CN119790052A (zh) * 2022-09-13 2025-04-08 金橘生物科技公司 苯并稠合的n-杂环及其用途
PE20252789A1 (es) 2023-05-24 2025-12-22 Kumquat Biosciences Inc Compuestos heterociclicos y usos de estos
KR20260040037A (ko) 2023-07-14 2026-03-23 카톨리에케 유니버시테이트 루벤 암 및 대사 질병의 치료를 위한 신규 화합물
CN119818693A (zh) * 2023-10-13 2025-04-15 华东师范大学 一种用于前药给药系统的可裂解支链连接体化合物及其制备和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US162A (en) 1837-04-17 Island
US5212A (en) 1847-07-31 Richard m
US4911920A (en) 1986-07-30 1990-03-27 Alcon Laboratories, Inc. Sustained release, comfort formulation for glaucoma therapy
FR2588189B1 (fr) 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
JP2594486B2 (ja) 1991-01-15 1997-03-26 アルコン ラボラトリーズ インコーポレイテッド 局所的眼薬組成物
UA94921C2 (en) * 2005-12-08 2011-06-25 Новартис Аг 1-orthofluorophenyl substituted 1, 2, 5-thiazolidinedione derivatives as ptp-as inhibitors
BR112020026086A2 (pt) * 2018-06-21 2021-03-23 Calico Life Sciences Llc inibidores da proteína tirosina fosfatase e métodos de uso destes
IL286373B2 (en) * 2019-03-14 2026-03-01 Calico Life Sciences Llc Protein tyrosine phosphate inhibitor compounds and uses thereof

Similar Documents

Publication Publication Date Title
JP2023507774A5 (https=)
JP2021530443A5 (https=)
ES2857649T3 (es) Inhibidores de serina/treonina cinasa
JP6409081B2 (ja) 治療活性化合物およびその使用方法
JP5311673B2 (ja) Ｍｅｋ阻害剤の使用方法
JP6529492B2 (ja) 癌の処置のためのｉｄｈ２突然変異体阻害剤としての２，４−または４，６−ジアミノピリミジン化合物
JP6648116B2 (ja) 変異イソクエン酸デヒドロゲナーゼ阻害剤としてのキノリノンピリミジン組成物
IL305077A (en) A quinazoline compound for inducing degradation of the G12D mutant cras protein
JP2014521696A (ja) セリン／スレオニンキナーゼインヒビターとしてのキナゾリン化合物
JP6490067B2 (ja) 治療活性化合物およびその使用方法
EA023420B1 (ru) Замещенные имидазопиридазины
JP2016525130A (ja) 治療活性化合物及びその使用
JP2010513288A5 (https=)
CN105980387A (zh) 丝氨酸/苏氨酸激酶抑制剂
CN103102342B (zh) 氨基喹唑啉类衍生物及其盐和使用方法
RU2010102992A (ru) Лиганды каннабиноидных рецепторов
JP2017505793A (ja) ｍＩＤＨ１阻害剤としてのベンズイミダゾール−２−アミン
EA030569B1 (ru) Замещенные бициклические дигидропиримидиноны и их применение в качестве ингибиторов активности нейтрофильной эластазы
JP2017508746A5 (https=)
JP2022543666A5 (https=)
CN103539777A (zh) Pi3激酶调节剂及其使用方法和用途
TW202227441A (zh) 喹唑啉化合物、包含其的藥物組合物及其應用
TW202237119A (zh) Ａｌｋ﹘５抑制劑和彼之用途
TW202206422A (zh) 用於ｃｄ７３調節之化合物及方法及其適應症
JP2025512935A5 (https=)